Risultati di ricerca
21 ore fa · Eli Lilly announced positive results from the phase 2 SYNERGY-NASH study evaluating tirzepatide for metabolic dysfunction-associated steatohepatitis (MASH) with stage 2 or 3 fibrosis. The study enrolled 190 patients and showed that 51.8% to 73.3% of participants achieved MASH resolution without worsening fibrosis, compared to 13.2% on placebo at 52 weeks.
9 giu 2024 · Economic Watch: China-Europe synergy turbocharges global transition to carbon-neutrality. Xinhua. 9th June 2024, 02:30 GMT+10. BEIJING, June 8 (Xinhua) -- In the high-tech district of Taicang, a city with less than one million residents in east China's Jiangsu Province, one can observe the influence of German enterprises at various bus stops ...
